WASHINGTON — The House moved Thursday to revive one of the more popular provisions of last year’s failed social safety net package, passing a narrow healthcare bill that would dramatically lower out-of-pocket costs for insulin users.
The bill passed by a vote of 232 to 193, with 12 House Republicans joining all Democrats in support.
The measure would cap insulin costs at $35 a month for consumers enrolled in both private health insurance plans and Medicare. Currently, based on the patient’s condition and choice of treatments, costs can range from $334 to $1,000 a month for insulin, according to a 2020 Kaiser Family Foundation report.
